These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 31173282

  • 1. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
    Li X, Zhang NX, Ye HY, Song PP, Chang W, Chen L, Wang Z, Zhang L, Wang NN.
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S, Liu S, Feng J, Gao J, Xue F.
    Cancer Biomark; 2019 Jan; 24(4):421-428. PubMed ID: 30909184
    [Abstract] [Full Text] [Related]

  • 3. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L.
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [Abstract] [Full Text] [Related]

  • 4. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH, Wang Y, Xu D.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J, Liu HR.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [Abstract] [Full Text] [Related]

  • 6. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
    Wu W, Gao H, Li X, Zhu Y, Peng S, Yu J, Zhan G, Wang J, Liu N, Guo X.
    Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, Li Y.
    BMC Cancer; 2019 Jun 24; 19(1):618. PubMed ID: 31234823
    [Abstract] [Full Text] [Related]

  • 8. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y, Feng SJ, Qiu S, Shao N, Zheng JH.
    Eur Rev Med Pharmacol Sci; 2017 Jul 24; 21(14):3176-3184. PubMed ID: 28770968
    [Abstract] [Full Text] [Related]

  • 9. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
    Yao N, Sun JQ, Yu L, Ma L, Guo BQ.
    Eur Rev Med Pharmacol Sci; 2019 Jun 24; 23(11):4642-4649. PubMed ID: 31210289
    [Abstract] [Full Text] [Related]

  • 10. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
    Zhang P, Zhang H, Wang Y, Zhang P, Qi Y.
    Med Sci Monit; 2019 May 07; 25():3366-3373. PubMed ID: 31062766
    [Abstract] [Full Text] [Related]

  • 11. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY, Wei P, Qu F.
    Eur Rev Med Pharmacol Sci; 2019 Jun 07; 23(11):4629-4641. PubMed ID: 31210304
    [Abstract] [Full Text] [Related]

  • 12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.
    J Exp Clin Cancer Res; 2017 May 08; 36(1):63. PubMed ID: 28482906
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH, Liu Y, Li JL.
    Biosci Rep; 2019 Aug 30; 39(8):. PubMed ID: 31337688
    [Abstract] [Full Text] [Related]

  • 14. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH, Wang Y, Xu D.
    Cancer Biomark; 2019 Aug 30; 25(2):193-201. PubMed ID: 31104012
    [Abstract] [Full Text] [Related]

  • 15. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
    Wang W, Jiang X, Xia F, Chen X, Li G, Liu L, Xu Q, Zhu M, Chen C.
    Mol Biol Rep; 2023 Jan 30; 50(1):453-464. PubMed ID: 36348197
    [Abstract] [Full Text] [Related]

  • 16. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L, Liu XL, Yuan Z, Cui J, Zhang H.
    Eur Rev Med Pharmacol Sci; 2019 Jun 30; 23(11):4663-4672. PubMed ID: 31210292
    [Abstract] [Full Text] [Related]

  • 17. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 30; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 18. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
    Shen F, Zong ZH, Liu Y, Chen S, Sheng XJ, Zhao Y.
    Biomed Pharmacother; 2019 Jun 30; 114():108787. PubMed ID: 30925458
    [Abstract] [Full Text] [Related]

  • 19. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
    Zhang L, Chen H, Ding B, Jiang W.
    J Ovarian Res; 2022 Feb 01; 15(1):19. PubMed ID: 35105347
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ, Lin XJ, Tang XY, Zheng TT, Zhang XY, Hua KQ.
    Int J Cancer; 2020 May 01; 146(9):2588-2598. PubMed ID: 31577838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.